• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Market Overview    



1.1 Product Overview and Scope of Tranexamic Acid  



1.2 Segment by Type    



1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030    

1.2.2 USP25    

1.2.3 BP2000

1.2.4 Other


1.3 Segment by Application  



1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030    

1.3.2    Trauma

1.3.3    Craniocerebral Trauma

1.3.4    Menorrhagia

1.3.5    Postpartum Hemorrhage

1.3.6    Surgery

1.3.7    Other Treatment

1.3.8    Whitening Cosmetics

1.4 Asia Pacific Market Growth Prospects    

1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)    

1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)  



2 Asia Pacific Growth Trends    



2.1 Industry Trends    

2.1.1 SWOT Analysis    

2.1.2 PESTEL Analysis    

2.1.3 Porter’s Five Forces Analysis    

2.2 Potential Market and Growth Potential Analysis    



3 Market Competition by Manufacturers  



3.1 Asia Pacific Production by Manufacturers (2019-2023)    

3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)    

3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)    

3.4 Asia Pacific Average Price by Manufacturers (2019-2023)    

3.5 Manufacturers Production Sites, Area Served, Product Type    

3.6 Market Competitive Situation and Trends    

3.6.1 Market Concentration Rate    

3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue    

3.6.3 Mergers & Acquisitions, Expansion  



4 Production by Region



4.1 Asia Pacific Production    

4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)    

4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)  



5 Consumption by Region  



5.1 Asia Pacific    

5.1.1 Asia Pacific Consumption by Country    

5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)    

5.1.1 China    

5.2.2 India

5.3.3 Japan

5.4.4 South Korea

5.5.5 Australia

5.6.6 Thailand

5.7.7 Indonesia


6 Segment by Type   



6.1 Asia Pacific Production Market Share by Type (2019-2024)    

6.2 Asia Pacific Revenue Market Share by Type (2019-2024)    

6.3 Asia Pacific Price by Type (2019-2024) 



7 Segment by Application  



7.1 Asia Pacific Production Market Share by Application (2019-2024)    

7.2 Asia Pacific Revenue Market Share by Application (2019-2024)    

7.3 Asia Pacific Price by Application (2019-2024)  



8 Key Companies Profiled    



8.1 CSL Limited    

8.1.1 CSL Limited Corporation Information    

8.1.2 CSL Limited Product Portfolio    

8.1.3 CSL Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.1.4 CSL Limited Main Business and Markets Served    

8.1.5 CSL Limited Recent Developments/Updates    

8.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.    

8.2.1 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Corporation Information    

8.2.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Product Portfolio    

8.2.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.2.4 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business and Markets Served    

8.2.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates    

8.3 JK Sucralose Inc.    

8.3.1 JK Sucralose Inc. Corporation Information    

8.3.2 JK Sucralose Inc. Product Portfolio    

8.3.3 JK Sucralose Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.3.4 JK Sucralose Inc. Main Business and Markets Served    

8.3.5 JK Sucralose Inc. Recent Developments/Updates    

8.4 Yunnan Baiyao Group Co., Ltd.    

8.4.1 Yunnan Baiyao Group Co., Ltd. Corporation Information    

8.4.2 Yunnan Baiyao Group Co., Ltd. Product Portfolio    

8.4.3 Yunnan Baiyao Group Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.4.4 Yunnan Baiyao Group Co., Ltd. Main Business and Markets Served    

8.4.5 Yunnan Baiyao Group Co., Ltd. Recent Developments/Updates    

8.5 OlainFarm    

8.5.1 OlainFarm Corporation Information    

8.5.2 OlainFarm Product Portfolio    

8.5.3 OlainFarm Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.5.4 OlainFarm Main Business and Markets Served    

8.5.5 OlainFarm Recent Developments/Updates    

8.6 Hisun Pharmaceuticals    

8.6.1 Hisun Pharmaceuticals Corporation Information    

8.6.2 Hisun Pharmaceuticals Product Portfolio    

8.6.3 Hisun Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.6.4 Hisun Pharmaceuticals Main Business and Markets Served    

8.6.5 Hisun Pharmaceuticals Recent Developments/Updates    

8.7 Pfizer Asia Pacific Pte. Ltd.    

8.7.1 Pfizer Asia Pacific Pte. Ltd. Corporation Information    

8.7.2 Pfizer Asia Pacific Pte. Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.7.3 Pfizer Asia Pacific Pte. Ltd. Main Business and Markets Served    

8.7.4 Pfizer Asia Pacific Pte. Ltd. Recent Developments/Updates    

8.8 Wanbang Biopharmaceuticals    

8.8.1 Wanbang Biopharmaceuticals Corporation Information    

8.8.2 Wanbang Biopharmaceuticals Product Portfolio    

8.8.3 Wanbang Biopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.8.4 Wanbang Biopharmaceuticals Main Business and Markets Served    

8.8.5 Wanbang Biopharmaceuticals Recent Developments/Updates    

8.9 Sun Pharmaceutical Industries Ltd.    

8.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information    

8.9.2 Sun Pharmaceutical Industries Ltd. Product Portfolio    

8.9.3 Sun Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.9.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served    

8.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates    

8.10 Torrent Pharmaceuticals Ltd.    

8.10.1 Torrent Pharmaceuticals Ltd. Corporation Information    

8.10.2 Torrent Pharmaceuticals Ltd. Product Portfolio    

8.10.3 Torrent Pharmaceuticals Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)    

8.10.4 Torrent Pharmaceuticals Ltd. Main Business and Markets Served    

8.10.5 Torrent Pharmaceuticals Ltd. Recent Developments/Updates    


9 Manufacturing Cost Analysis    



9.1 Key Raw Materials Analysis    

9.1.1 Key Raw Materials    

9.1.2 Key Suppliers of Raw Materials    

9.2 Proportion of Manufacturing Cost Structure    

9.3 Manufacturing Process Analysis of Tranexamic Acid     

9.4 Industrial Chain Analysis    



10 Marketing Channel, Distributors and Customers  



 10.1 Marketing Channel    

10.2 Distributors List    

10.3 Customers    



11 Market Dynamics



11.1 Industry Trends    

11.2 Market Drivers    

11.3 Market Challenges    

11.4 Market Restraints    



12 Production and Supply Forecast



12.1 Asia Pacific Production, Revenue Forecast (2024-2030)    



13 Consumption and Demand Forecast  



 13.1 Asia Pacific Forecasted Consumption of by Country    



14 Forecast by Type and by Application  



14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)    

14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)    

14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)    

14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)    

14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)    

14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)    

14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)    

14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)  



15 Research Findings and Conclusion   



16 Methodology and Data Source    



16.1 Methodology/Research Approach    

16.1.1 Research Programs/Design    

16.1.2 Market Size Estimation    

16.1.3 Market Breakdown and Data Triangulation    

16.2 Data Source    

16.2.1 Secondary Sources    

16.2.2 Primary Sources    

16.3 Author List    

16.4 Disclaimer    



17 Appendix    



17.1 Note    

17.2 Examples of Clients